Bioglass Fiber Market Size By Type (Conventional Silicate Glass, Glass Ceramics, Borate-Based Glasses), By Raw Material (Silicone Resins & Dioxide, Calcium & Sodium Carbonates, Sodium Phosphate Dibasic), By Application (Dental, Orthopedic, Grafting Biomat

Bioglass Fiber Market Size By Type (Conventional Silicate Glass, Glass Ceramics, Borate-Based Glasses), By Raw Material (Silicone Resins & Dioxide, Calcium & Sodium Carbonates, Sodium Phosphate Dibasic), By Application (Dental, Orthopedic, Grafting Biomaterials), Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Landscape & Forecast, 2023 - 2032

The global bioglass fiber market is poised to record strong growth through 2032, fueled by the increasing number of dental clinics in North America. Bioglass fiber has a plethora of used in the oral health sector owing to their properties.

Major corporations operating in the industry are investing heavily towards R&D initiatives to elevate their market presence. Many organizations are also turning to mergers and acquisitions to retain their competitive edge in the industry landscape.

For instance, in September 2021, the Heraeus Group, a global family-owned portfolio corporation, acquired ETS Technology Holdings LLC, a developer of wound care technology, as well as Mo-Sci Corporation, a market leader in the production of medical and specialty glass to enhance their footing in the sector.

Through the takeover, Heraeus would be able to offer new tools and services to its to customers while also delivering cutting-edge medical treatments and innovative technology that will improve their health outcomes. ETS had recently received an approval from the US FDA for its latest product, Mirragen, which is a resorbable synthetic skin replacement. The company is still developing the technology for additional uses.

The bioglass fiber market has been bifurcated in terms of type, raw material, application, and region.

In terms of type, the borate-based glasses (BBG) segment is projected to attain high gains credited to its wide range of uses in biomedical applications. Compared to silicate glasses, BBG usually has better bioactivity and bone healing potential. It makes for a better option for drug delivery processes for the treatment of infections or diseases such as osteoporosis. Additionally, BBGs are a suitable for applications involving wound healing, including the provision of commercial (FDA-approved) microfibrous BBG dressings for treating chronic wounds.

Based on raw material, the sodium phosphate dibasic segment is speculated to grow at 7.5% CAGR from 2023 to 2032. The segment expansion is expected to be fueled by increasing development of traditional silicate glass fibers and the widespread use of these fibers in dental and orthopedic treatments in US and Europe.

With respect to application, the industry has been divided into dental, grafting biomaterials, orthopedic, and others. The others segment is anticipated to record strong growth owing to an increasing demand from numerous medical practices. Healthcare professionals are increasingly incorporating the materials in their clinical procedures as a result of surging healthcare marketing and promising in-vivo outcomes.

From the regional perspective, the Asia Pacific bioglass fiber industry is slated to surpass a $2 billion valuation by 2032. Swift expansion of the healthcare sector in countries such as India, China, Malaysia, Indonesia, and South Korea is likely to create favorable opportunities for strong market growth.